Today's Healthcare Pulse
Allogene Therapeutics CEO David Chang to step down
Allogene Therapeutics announced that chief executive David Chang will leave his role. The news was reported by STAT+ and echoed in a follow‑up piece covering broader pharma updates.
Also developing:
By the numbers: Boston Scientific invests $1.5B for 34% stake in MiRus
Best Dentists in Forest Hills for Implants and Cosmetic Dentistry
Advancements in restorative and cosmetic dentistry have driven demand for high-quality implant and smile‑makeover services in Forest Hills, Queens. This guide ranks three leading practices—VIP Dental Care, Gentle Dental Family Care, and Forest Hills Dental—based on clinician credentials, modern technology, safety protocols, material quality, and transparent pricing. The clinics collectively offer a full spectrum of treatments, from teeth whitening and bonding to full‑mouth implants and Invisalign, serving thousands of satisfied patients. Prospective patients are advised to evaluate specialist experience, technology use, and patient reviews when selecting an implant provider.
Anavex Withdraws EU Application for Alzheimer’s Drug Blarcamesine
Anavex Life Sciences has withdrawn its European marketing authorisation application for blarcamesine, a small‑molecule therapy aimed at early Alzheimer’s disease, after the EMA’s Committee for Medicinal Products for Human Use concluded in December 2025 that the drug’s benefits did not...
Eindhoven’s ONWARD Medical Raises €40.6 Million in Capital Increase to Advance Spinal Cord Injury Therapies
ONWARD Medical, the Dutch neurotechnology firm behind the ARC‑EX spinal‑cord stimulation system, completed a €40.6 million (≈$44 million) accelerated book‑build private placement, issuing 13.5 million new shares at €3 each. The round includes a €25 million (≈$27 million) commitment from EQT Life Sciences and other...
First Patient Receives JANX014 Dose in Janux’s Trial for mCRPC
Janux Therapeutics announced the dosing of its first patient in a Phase I trial of JANX014, a prostate‑specific membrane antigen (PSMA)‑directed T‑cell engager for metastatic castration‑resistant prostate cancer (mCRPC). The multicenter, open‑label study will evaluate safety, tolerability, pharmacokinetics, pharmacodynamics and early...
Heidi Launches First Hardware Designed For Reliable Audio Capture in Every Clinical Setting
UK‑based AI health platform Heidi has launched Heidi Remote, a purpose‑built wearable microphone for reliable audio capture in clinical settings. The device replaces phones and laptops, offering 14 hours of battery life, offline recording, and hospital‑grade durability to improve AI‑scribe transcription...
Listen: With Little Federal Regulation, States Are Left To Shape the Rules on AI in Health Care
The White House and several states are at odds over how to regulate artificial intelligence in health care, leaving states to fill the regulatory vacuum. Maryland and Virginia illustrate the split, with each adopting distinct rules for AI use in...
Families Left Reeling After Hospitals in Blue States Drop Transgender Care for Youth
A wave of hospitals in traditionally supportive blue states is ending gender‑affirming care for minors after the Trump administration threatened to cut Medicaid and Medicare reimbursements. Baystate Health in Massachusetts announced in February 2026 that it would stop prescribing hormone therapy...
Weekly Neuroscience Update
Researchers unveiled a fully implantable brain‑computer interface that lets paraplegic patients control a robotic exoskeleton with their thoughts, aiming to restore both walking and its sensation. Parallel advances include an AI pruning framework that mimics infant brain development to slash...
Doctolib, AP-HP, and Roche Launch Startup Programme to Bridge Healthtech–Clinical Gap
Doctolib, AP‑HP’s Hôtel‑Dieu, and Roche have launched Care Forward, a health‑tech accelerator housed at Station F. The program pairs Doctolib’s software know‑how, AP‑HP’s hospital network access, and Roche’s regulatory expertise to help European startups test and scale solutions that measurably...
Bavarian Nordic Reports Swissmedic’s Approval of Vimkunya to Prevent Chikungunya
Swissmedic has granted approval to Bavarian Nordic’s Vimkunya, a single‑dose, virus‑like particle vaccine for chikungunya, targeting individuals 12 years and older. The vaccine is designed to elicit protective immunity as early as one week after injection. Bavarian Nordic has also...
Q&A with National Health Council: Driving Patient-Centred Policy
The National Health Council (NHC), a century‑old coalition of health stakeholders, is championing patient‑centered policy as the U.S. grapples with new payment models and drug‑price reforms. Its advocacy secured patient input in the Inflation Reduction Act’s Initial Price Applicability Year...
South Korea’s Healthcare Boom Creates New Billionaires
South Korea’s healthcare sector is rapidly generating wealth, propelling several pharma executives onto the nation’s richest list. Sam Chun Dang Pharm’s weight‑loss partnership with Japan’s Daiichi Sankyo lifted chairman Yoon Dae‑in to a $5.9 billion net worth, while ABL Bio and Voronoi secured multibillion‑dollar deals that...
The Rise of Virtual Therapy Platforms in Healthcare
Virtual therapy platforms have surged into mainstream healthcare, offering patients flexible, cost‑effective mental health care through video, audio, and text channels. The COVID‑19 pandemic accelerated adoption, normalizing remote sessions and prompting providers to integrate digital tools. Advances such as AI‑driven...
Resilience by Design: Building a National Network for Ambulance Services
The Ambulance Radio Programme (ARP) has built a national, dual‑data‑centre network that links 35 NHS trust sites, ensuring 24/7 availability of mission‑critical ambulance communications. Partnering with Vysiion, ARP introduced a dedicated Network Operations Centre and managed services to monitor, patch,...
Cast Works as Well as Surgery for Kids' Wrist Fractures
Most children with severely displaced wrist fractures can achieve similar long-term recovery with a plaster cast instead of surgery, minimizing risks and reducing healthcare costs. pediatrics
High SHBG Increases Sarcopenia Risk; Free Hormones Protect
Endogenous sex hormones, sex hormone-binding globulin, and muscle health: insights into sarcopenia and sarcopenic obesity from the Women’s Health Initiative "Among postmenopausal women, higher SHBG concentrations at baseline were associated with lower lean body mass and a higher odds of sarcopenia,...
Radiopharm Completes Final Patient Dosing of RAD 101 for Diagnosis of Brain Metastases in the US
Radiopharm Theranostics announced the final patient dosing in its U.S. Phase IIb trial of the 18F‑RAD101 PET imaging agent for recurrent brain metastases. The study enrolled 30 patients and interim results demonstrated 90% concordance with MRI, meeting the predefined efficacy...
Automating Behavioral Health Utilization Review to Reduce Denials
A Johns Hopkins study found that 1 in 10 U.S. adults experienced a mental‑health crisis in 2025, underscoring soaring demand for behavioral health services. Most facilities still rely on manual utilization review (UR) using spreadsheets and shared inboxes, which creates...
Never Withdraw Care without Direct Observation
Why I would never compromise on withdrawing care until I saw it firsthand [PODCAST] http://dlvr.it/TS4mMD Podcast #PalliativeCare
£1m Longitude Prize Awarded to “Revolutionary” AI Smart Glasses Companion for People Living with Dementia
The Longitude Prize on Dementia awarded a £1 million (~$1.25 million) grand prize to CrossSense for its AI‑powered smart‑glasses companion, Wispy. The device uses computer‑vision and voice prompts to identify objects and guide early‑stage dementia patients through daily routines, learning each user’s...
![[Emergency Pod] Peptides - Part 1 with Sunita Mohanty of Ultralight](/cdn-cgi/image/width=1200,quality=75,format=auto,fit=cover/https://megaphone.imgix.net/podcasts/d0db1eda-2c6f-11ef-958d-9fb4aba9c1ce/image/0bfc12f76c8a92fdb53253e1c884033d.jpg?ixlib=rails-4.3.1&max-w=3000&max-h=3000&fit=crop&auto=format,compress)
[Emergency Pod] Peptides - Part 1 with Sunita Mohanty of Ultralight
In this episode of Lifers, host Christina Farr talks with Sunita Mohanty, CEO and co‑founder of Ultralight, about the booming interest in peptide therapies for wellness and longevity. Sunita explains that while peptides are gaining popularity—driven by anecdotal success, recent...
NTU's AI Chip Detects Disease Biomarkers in 20 Minutes and More Briefs
Researchers at Singapore’s NTU unveiled an AI‑enabled nanophotonic chip that detects microRNA disease biomarkers in about 20 minutes, bypassing traditional PCR methods. South Korea’s Neurophet raised $21.6 million to expand its AI brain‑imaging platform for Alzheimer’s and other neuro‑conditions, targeting the...
Philips Receives US FDA 510(k) Clearance for AI-Powered Spectral CT Verida System
Philips has obtained FDA 510(k) clearance for its Verida spectral CT system, the world’s first AI‑powered detector‑based spectral CT platform. The system combines always‑on spectral imaging with deep‑learning reconstruction, delivering higher image quality, lower noise, and enhanced tissue characterization. It...
PET‑CT Leak Linked to Staff Cancer Cases
The 3D precision of a PET-CT scan is designed to find cancer, but at one government teaching hospital, the machine itself is being blamed for causing it. Seven personnel in a single radiology department have developed cancer or thyroid diseases. You...
Leiden University Seeks Postdoc for Next‑gen GPCR Drug Discovery
🚨 Hiring Postdoctoral candidate for next generation GPCR drug discovery Leiden University The Faculty of Science and the Leiden Academic Centre for Drug Research (LACDR) are looking for a:Postdoctoral candidate for next generation GPCR drug discoveryAre you excited about developing cutting-edge drug...
Hippocratic AI Launches Safety-First Voice AI for Patients and Nurses
Healthcare AI startup Hippocratic AI unveiled two voice‑driven solutions: AI Front Door, a patient‑facing omni‑topic agent, and Nurse Co‑Pilot, a bedside assistant for inpatient nurses. AI Front Door consolidates scheduling, lab results, billing and care follow‑ups into a single, relationship‑based...
New Rogan‑Spotify Alliance Fuels Anti‑vax Disinformation, Endangering Children
I’m not happy about this new toxic alliance between Children’s Health Defense and Rogan-Spotify. Both are powerful anti-science disinformation organizations, and they don’t care about you or your family. We already had >200,000 needless American deaths from pushing ivermectin and...
Weekly System Review Fuels MYRESET’s Patient Care
Founder Diaries Day 5? — Weekly regroup of our systems, targets & goals for MYRESET at our favorite lounge 💉💚⏰ (We’re also “on call” for our patients booked in for consults all the time. We make sure our doctors are...
Stockholm’s BioLamina Secures €20 Million EIB Loan to Scale Cell Therapies for Chronic Diseases
Swedish biotech scale‑up BioLamina secured a €20 million (≈$22 million) venture‑debt loan from the European Investment Bank to accelerate its laminin‑based cell‑culture platform. The financing will fund expansion of manufacturing capacity, broaden the product portfolio and reinforce the company’s technology base for...
Want to Get the Pill without Seeing a GP? Here’s What You Need to Know
Australian states are expanding pharmacy access to oral contraceptives, with New South Wales set to let eligible pharmacists prescribe the pill to women 18 and older from June 2026. Victoria already permits first‑time users to obtain the pill at pharmacies...
Zantac Suits Tossed by Delaware Judge for Flawed Cancer Link
A Delaware Superior Court judge dismissed all pending Zantac cancer lawsuits, finding plaintiffs failed to provide credible evidence linking the heartburn drug to cancer. The ruling frees Sanofi, GSK, Pfizer and Boehringer from further state‑court trials in Delaware. The decision...
France Makes Reusable Period Products Free for Young Women
France's social security system will reimburse reusable menstrual cups and underwear for women under 26 and for low‑income women, starting in the autumn academic year. The measure, approved in the 2024 social security budget, aims to assist roughly 6.7 million people,...
Celebrating Science: Discussing #ScienceUnderSiege with Neil Tyson
After so many dark months of countering RFK Jr and the ACIP/HHS/Children’s Health Offense pseudoscience disinformation campaign it was a real joy to spend an evening with @neiltyson discuss our book #ScienceUnderSiege @MichaelEMann @PeterHotez https://t.co/49e3hC7bSz
'Self-Regulating' Wound Patch Developed in South Korea
Researchers at KAIST unveiled a self‑regulating wound‑healing patch that merges a 630‑nm organic LED with a ROS‑triggered drug delivery system. The OLED emits uniform light to stimulate cell regeneration while nanocarriers release Centella asiatica extract in proportion to the generated...
Woo Truce? The Science and Health Establishment Divided on How to Deal with MAHA and RFK, Jr.
The Trump administration unveiled new meat‑ and milk‑focused dietary guidelines at an event featuring Robert F. Kennedy Jr. and his Make America Healthy Again (MAHA) coalition. AMA President Bobby Mukkamala attended, highlighting the medical community’s split over the administration’s push...
Which Allergy Medicine Works Best?
Allergist Dr. Dylan Timberlake explains that second‑generation antihistamines, nasal steroid sprays, and short‑term decongestants each have distinct roles in allergy relief. Newer antihistamines like Zyrtec, Claritin, Allegra, and Xyzal offer similar efficacy with minimal drowsiness, while nasal steroids such as...
Live From TAHFM 2026: Facility Leaders & Conference Highlights
The episode recaps the Texas Association of Healthcare Facilities Managers (TAHFM) 2026 conference, highlighting the industry’s triple aging crisis—workforce, buildings, and infrastructure—and how the Healthcare Facilities Network is addressing it. Guests, including facility leaders Jim, David Trask, Joe Stockman, and...
Does the Brain Really Make Its Own DMT? New Study Ignites Debate
A new study by Mikael Palner at the University of Southern Denmark examined rat brains ex vivo and found no detectable endogenous N,N‑dimethyltryptamine (DMT) in serotonin‑producing neurons, despite using MAO inhibitors to block degradation. This contrasts sharply with a 2019 microdialysis...
Establishing 5G Connectivity to Enable a Smart Regional Health System
Singapore’s National University Health System (NUHS) has signed a strategic agreement with GSMA Foundry to embed private 5G across its hospital cluster. The partnership will integrate 5G private networks with digital twins, XR, IoT and ambient AI to accelerate remote...
Cough Drops From Several Brands Being Recalled, FDA Says
On March 20, the FDA initiated a Class II recall of 15 cough‑drop products sold under five private‑label brands after an inspection of the Chinese manufacturer Xiamen Kang Zhongyuan Biotechnology revealed unspecified concerns. The affected items, many bearing lot 20241030 and expiring...
Medical Assistance in Dying: Thoughtful Planning at End of Life
Canada’s medically assisted dying (MAID) program is a tightly regulated service that lets eligible adults end intolerable suffering with physician‑administered medication. The law does not require a terminal diagnosis, but patients must have decision‑making capacity, a serious incurable illness, and...
Enough Will They-Won’t They! FDA Pushes for Permanent Rare Pediatric Disease PRVs
The FDA’s FY2027 budget request asks Congress to make the Rare Pediatric Disease (RPD) Priority Review Voucher program permanent, ending its four‑year reauthorization cycle. A voucher lets sponsors shave FDA’s review time from ten to six months and can be...
Novo Nordisk Partners with OpenAI to Speed AI-Driven Drug Discovery
Novo Nordisk has struck a partnership with OpenAI to use generative AI for drug discovery, aiming to cut development timelines. The announcement lifted Novo’s stock 2.8% and intensifies its race with Eli Lilly for a share of the $100 bn obesity market.
Warren and Hawley Introduce Bill to Bar Vertical Integration of Insurers, PBMs and Providers
Senators Elizabeth Warren and Josh Hawley have introduced the Break Up Big Medicine Act, a bipartisan bill that would prohibit parent companies from simultaneously owning insurers, pharmacy‑benefit managers, providers or wholesalers. The measure seeks to dismantle vertically integrated health‑care giants...
FDA Receives sBLA for Zenocutuzumab Targeting NRG1‑Positive Cholangiocarcinoma
Partner Therapeutics submitted a supplemental Biologics License Application for Zenocutuzumab in advanced NRG1‑fusion cholangiocarcinoma, prompting the FDA to accept the filing and the NCCN to list the drug as a Category 2A/2B option. The move follows a phase 2 trial that showed...
Kailera Raises $625M in Major Biotech IPO
From @gwendolynawu: Kailera nets $625M in one of biotech’s biggest-ever IPOs https://t.co/SJWx2QBmSn $KLRA #biotech $LLY $NVO $GPCR $VKTX #IPO
7‑8 Hours Nightly Cuts Type 2 Diabetes Risk
This Is How Much Sleep You Need to Lower Your Type 2 Diabetes Risk https://t.co/UI9VyQiv3a https://t.co/ac9eBXPIBu
Biotech Insights - Spring 2026
The FDA’s post‑approval change framework now spotlights GLP‑1 products, exemplified by Wegovy’s tablet approval, and mandates reporting based on the change’s impact—major and moderate changes require supplemental NDAs, while minor changes go in the annual report. In parallel, the Federal...
Review Panel Finds Anti‑amyloid Alzheimer Drugs Offer Little Benefit
Medical Review Group Questions Usefulness of Some Alzheimer’s Drugs Group says anti-amyloid treatments don’t offer noticeable benefits https://t.co/Z9tRQquyZX
Will Retatrutide Help Me Lose Weight or Look ‘Shredded’?
Retatrutide, an experimental triple‑hormone peptide, has shown more than 20% body‑weight loss in a 48‑week clinical trial, outperforming existing GLP‑1 drugs like Ozempic and Wegovy. Researchers say it works by modulating GLP‑1, GIP and glucagon pathways to suppress appetite and...